This invention relates to a medical device and more particularly to an open lumen ureteral stent having reduced mass.
Known ureteral stents are typically placed within a urinary tract of a patient to, for example, assist with urinary flow from the kidney to the bladder, or help support a damaged or weakened ureter. Typically, such stents are longitudinally backloaded onto a guidewire to enable insertion and placement of the stent. Backloading of a stent onto a guidewire can require significant time and effort by the physician. Additionally, known ureteral stents often cause discomfort to the patient once the ureteral stents are positioned within the body due to the size and mass of the stent. Some ureteral stents include one or more retention members that further add to the mass of the stent. Such retention members can be positioned within a ureter, bladder and/or kidney of a patient to help retain the ureteral stent in place within the urinary tract of the patient. The large mass of some retention members may not easily conform to the bladder when the bladder is emptied or collapsed, which can result in patient discomfort. Further discomfort can also result when the ureteral stent is removed from a patient due to the size and configuration of the stent and/or retention member.
Thus, a need exists for a ureteral stent having reduced mass that is sufficiently strong to allow urinary flow therethrough. There is also a need for a stent that can laterally receive a guidewire through an opening in the stent to assist in placement of the stent.
A stent according to an embodiment of the invention includes an elongate body having a proximal end portion and a distal end portion. The elongate body defines a lumen and an opening in communication with the lumen between the proximal end portion and the distal end portion. The lumen is configured to enable the flow of fluid therethrough. The opening has a width greater than half the size of a diameter of the lumen and less than the diameter of the lumen. The opening also has a length at least twice the width of the opening. In some embodiments, the opening is configured to laterally receive a guidewire therethrough. The elongate body can be configured to releasably couple the guidewire within the lumen of the elongate body such that the elongate body can be slidably moved along the guidewire.
The present invention is described with reference to the accompanying drawings.
The medical devices described herein can be inserted into a body lumen of a patient, such as, for example, a urinary tract. For example, a medical device can be configured as a urinary stent that defines a lumen to enable the flow of urine therethrough. A medical device according to an embodiment of the invention can define a lumen and an opening in communication with the lumen. The opening can be defined between a proximal end and distal end of the medical device, and in some embodiments can extend the entire length of the medical device. In such an embodiment, the opening can laterally receive a guidewire therethrough. The medical devices described herein can provide a stent that has reduced mass and increased patient comfort. In some embodiments, an opening defined by the medical device extends through retention members disposed at ends of the medical device, which provides more flexibility of the retention members and further reduces the mass of the device.
In one embodiment, a stent includes an elongate body having a proximal end portion and a distal end portion. The elongate body defines a lumen and an opening in communication with the lumen between the proximal end portion and distal end portion allowing fluid flow therethrough. The opening has a width greater than half the size of a diameter of the lumen and less than the diameter of the lumen. The opening also has a length at least twice the width of the opening. In another embodiment, a ureteral stent includes an opening that extends from a proximal end to a distal end of the elongate body. The opening is configured to laterally receive a guidewire therethrough. The elongate body is configured to releasably couple the guidewire within a lumen of the elongate body such that the elongate body can be slidably moved along the guidewire.
The stent 100 includes an elongate body 102 having a proximal end portion 104 and a distal end portion 106 and defines a lumen (not shown in
The opening 108 can extend along a portion of the elongate body 102 or extend from the proximal end to the distal end of the elongate body 102. In some embodiments, where there are more than one openings 108, the openings 108 can be defined at spaced locations along a length of the elongate body 102. In some embodiments, the opening 108 can have a width greater than a radius of the lumen, but less than a diameter of the lumen. The opening 108 can also have a length at least twice its width.
The opening(s) 108 reduce the overall mass of the stent 100 to provide improved patient comfort and facilitate fluid flow through the stent 100. In some embodiments, where the opening 108 extends the entire length of the elongate body 102 (e.g., from the proximal end to the distal end), a guidewire 116 can be laterally received through the opening 108 and releasably coupled within the lumen of the elongate body 102. For example, the portions of the elongate body 102 bounding the opening 108 can flex to allow the insertion of the guidewire 116 therethrough. Once the guidewire 116 is disposed within the lumen of the stent 100, the portions of the elongate body 102 bounding the opening 108 return to a non-flexed configuration and retain the guidewire 116 within the lumen of the elongate body 102. The elongate body 102 can slidably move along the guidewire 116 to be placed into a desired position within a body lumen of a patient, such as within a urinary tract of the patient via a pusher device 114. Alternatively, the stent 100 may be backloaded onto the guidewire 116 longitudinally and directed into the desired position within the urinary tract of the patient via the pusher device 114. After placement of the stent 100, the guidewire 116 can be removed from the patient. The pusher 114 can be removed from the guidewire 116 either before or after removing the guidewire 116 from the patient.
The stent 100 can also include one or more retention members configured to retain or anchor the stent 100 within a body lumen of a patient, such as within a urinary tract. A retention member 110 can be disposed at the proximal end portion 104 and/or a retention member 112 can be disposed at the distal end portion 106. The retention members 110 can be used, for example, to help retain the stent 100 within a bladder or ureter of a patient, and the retention member 112 can be used, for example, to help retain the stent 100 within a kidney, or ureter of the patient. The retention members 110 and 112 can be coupled to, or formed integrally with the elongate body 102. The retention members 110 and 112 can have a cross-section substantially the same as, or different from the elongate body 102 and the same as or different than each other. The retention members 110 and 112 can have a variety of different shapes, sizes and configurations including for example, J-shaped, coiled or pigtail-shaped, or any other known configuration for retention of a stent within a body lumen. The retention members 110, 112 can also be expandable, for example, when exposed to fluid within a body lumen.
The elongate body 102 can have a variety of different cross-sectional profiles, and can have different cross-sectional configurations at different locations along a length of the elongate body 102. The elongate body 102 can also define one or more channels (not shown in
As stated above, the pusher device 114 (also referred to herein as “pusher”) can be used to insert the stent 100 within a body lumen of a patient. The pusher 114 can have a similar configuration as the stent 100. For example, the pusher device 114 can include an elongate body that defines a lumen (not shown in
Having described above various general principles, several exemplary embodiments of these concepts are now described. These embodiments are only examples, and many other configurations of a medical device and its various components are contemplated by the principles of the invention, and will be apparent to the artisan in view of the general principles described above and the exemplary embodiments. In addition, various other methods and medical procedures can be performed using the medical devices described herein.
The stent 200 also includes a retention member 210 associated with the proximal end portion 204, and a retention member 212 associated with the distal end portion 206. The retention members 210 and 212 are substantially J-shaped, but other configurations can alternatively be used. In this embodiment, the retention members 210, 212 are formed integral with the elongate body 202. As shown in
In this embodiment, the opening 208 and lumen 218 extend between a proximal end and a distal end along the entire length of the elongate body 202 including the retention members 210, 212, as shown in
As shown in
As stated previously, the stent 200 can be laterally loaded onto a guidewire 216 for insertion into a body lumen. For example, a guidewire 216 can be placed within a body lumen of a patient and then the stent 200 can be placed on the guidewire 216 by laterally passing the guidewire 216 through the opening 208 of the stent 200.
A stent 600 illustrated in
In an alternative embodiment, shown in
The stent (e.g., stent 100, 200, etc.) and pusher (e.g., 814, 914) may be formed from a number of various biocompatible materials used in medical devices. The stent and/or pusher may include one material or may be formed, for example by extrusion, of two or more materials along its length. For example, in one embodiment, a distal end portion of the elongate body can be formed from a first material and the proximal end portion can be formed from a different second material. Accordingly, the proximal end portion may be made of a softer material than that of the distal end portion, and vice versa. Likewise, the retention members (e.g., 110, 112) can be formed with the same or different material than each other and/or the elongate body.
The elongate body and the retention member can be formed from any material or materials known in the art to be used in constructing ureteral stents. One subset of biocompatible materials best suited for the elongate body exhibit at least some of the following characteristics: high tensile strength, high retention coil strength, excellent biocompatibility and biodurability, excellent radiopacity or fluoroscopic visibility, availability in varying durometers, and a low resistance to passage. For example, in one embodiment, the elongate body is formed with a polymeric material.
In some embodiments, a kit can be provided that includes one or more ureteral stent and one or more pusher device as described herein. For example, a kit can include a ureteral stent, such as stent 200, and a pusher, such as pusher 814 or 914. As described above, the stent can define a lumen and an opening in communication with the lumen along at least a portion of a length of the stent. In some embodiments, the stent is configured to laterally receive a guidewire through the opening. Likewise, the pusher can be configured to laterally receive a guidewire through an opening along a length of the pusher. In some embodiments, a kit can also include one or more guidewires used for insertion of the stent into a ureter.
While various embodiments of the invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of the invention should not be limited by any of the above-described embodiments, but should be defined only in accordance with the following claims and their equivalents. While the invention has been particularly shown and described with reference to specific embodiments thereof, it will be understood that various changes in form and details may be made.
The previous description of the embodiments is provided to enable any person skilled in the art to make or use the invention. While the invention has been particularly shown and described with reference to embodiments thereof, it will be understood by those skilled in art that various changes in form and details may be made. For example, a stent and/or pusher device can include various combinations and sub-combinations of the various embodiments described herein. In addition, a stent can include one or more of the features described with reference to a pusher device, and vice versa. For example, a stent can include tabs as described in the embodiment of a pusher.
This application claims priority to U.S. Provisional Application Ser. No. 60/917,799, entitled “Open Lumen Stent,” filed May 14, 2007, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4225979 | Rey et al. | Oct 1980 | A |
4307723 | Finney | Dec 1981 | A |
4334327 | Lyman et al. | Jun 1982 | A |
4643716 | Drach | Feb 1987 | A |
4790809 | Kuntz | Dec 1988 | A |
4950228 | Knapp et al. | Aug 1990 | A |
5019102 | Hoene | May 1991 | A |
5052998 | Zimmon | Oct 1991 | A |
5141502 | Macaluso, Jr. | Aug 1992 | A |
5306300 | Berry | Apr 1994 | A |
5599291 | Balbierz et al. | Feb 1997 | A |
5647843 | Mesrobian et al. | Jul 1997 | A |
5651767 | Schulman et al. | Jul 1997 | A |
5681274 | Perkins et al. | Oct 1997 | A |
5766209 | Devonec | Jun 1998 | A |
5782916 | Pintauro et al. | Jul 1998 | A |
5795319 | Ali | Aug 1998 | A |
5964744 | Balbierz et al. | Oct 1999 | A |
5971967 | Willard | Oct 1999 | A |
5984965 | Knapp et al. | Nov 1999 | A |
5989207 | Hughes | Nov 1999 | A |
6063119 | Pintauro et al. | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6132364 | Rottenberg et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6214037 | Mitchell et al. | Apr 2001 | B1 |
6524268 | Hayner et al. | Feb 2003 | B2 |
6709465 | Mitchell et al. | Mar 2004 | B2 |
6908447 | McWeeney et al. | Jun 2005 | B2 |
6929664 | Kolb | Aug 2005 | B2 |
7041139 | Bluni et al. | May 2006 | B2 |
7182745 | Desmond, III | Feb 2007 | B2 |
7217250 | Kolb | May 2007 | B2 |
7316663 | Whitmore, III | Jan 2008 | B2 |
7338530 | Carter et al. | Mar 2008 | B2 |
7731676 | Maeda | Jun 2010 | B2 |
7972292 | Behl et al. | Jul 2011 | B2 |
7996976 | Desmond, III | Aug 2011 | B2 |
8007540 | Robertson | Aug 2011 | B2 |
8007702 | Gellman | Aug 2011 | B2 |
8398705 | Mangiardi | Mar 2013 | B2 |
20010053936 | Whitmore, III | Dec 2001 | A1 |
20030195456 | Robertson | Oct 2003 | A1 |
20040181186 | Gellman et al. | Sep 2004 | A1 |
20050060023 | Mitchell et al. | Mar 2005 | A1 |
20050125072 | Kolb | Jun 2005 | A1 |
20090156977 | Daignault et al. | Jun 2009 | A1 |
20100179666 | Amos, Jr. | Jul 2010 | A1 |
Number | Date | Country |
---|---|---|
19806507 | Aug 1999 | DE |
WO 02098500 | Dec 2002 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US08/63581, mailed on Feb. 3, 2009; 17 pages. |
Communication Relating to the Results of the Partial International Search for International Patent Application No. PCT/US03/11879, 4 pages. |
International Search for International Patent Application No. PCT/US03/11879, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20080288082 A1 | Nov 2008 | US |
Number | Date | Country | |
---|---|---|---|
60917799 | May 2007 | US |